227 results
8-K
EX-99.1
HAE
Haemonetics Corp.
1 Apr 24
Haemonetics Corporation Completes Acquisition of Attune Medical
8:01am
) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient … care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite
8-K
EX-99.1
HAE
Haemonetics Corp.
5 Mar 24
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
6:10am
healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce … the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital
8-K
EX-99.1
HAE
Haemonetics Corp.
8 Feb 24
Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2024 Results; Updates Fiscal 2024 Guidance
6:05am
: https://edge.media-server.com/mmc/p/unynzc8w
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing … a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology
8-K
EX-99.1
HAE
Haemonetics Corp.
12 Dec 23
Other Events
6:09am
Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions … for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma
8-K
EX-99.1
n08qf
2 Nov 23
Haemonetics Reports Second Quarter and First Half Fiscal 2024 Results; Updates Fiscal 2024 Guidance
6:16am
8-K/A
EX-2.1
k9282tx
12 Oct 23
Financial Statements and Exhibits
6:10am
8-K
EX-99.1
1zewesou3 5g5vlw2z
10 Oct 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
2jq8pve27jl6tzvx87en
8 Aug 23
Haemonetics Reports First Quarter Fiscal 2024 Results; Updates Fiscal 2024 Guidance
6:01am
8-K
EX-99.1
fnhte9q5
7 Aug 23
Departure of Directors or Certain Officers
4:19pm
SD
EX-1.01
fo43hyhc
30 May 23
Conflict minerals disclosure
5:02pm
8-K
EX-99.1
kwlmgxo612nd7j5vq
11 May 23
Results of Operations and Financial Condition
6:05am
8-K
EX-99.1
z8hz6m5 mou
7 Nov 22
Haemonetics Reports Second Quarter and First Half Fiscal 2023 Results; Updates Fiscal 2023 Guidance
6:03am